Key result
Individual statins show distinct safety profiles, linking atorvastatin to hearing loss and rosuvastatin to skeletal events.
Why the study?
Do various types of statins cause distinct adverse drug reactions in the FAERS database?
Observational
Do various types of statins cause distinct adverse drug reactions in the FAERS database?
This pharmacovigilance study identified both shared and distinct safety signals among different statins, suggesting the need for tailored clinical considerations based on specific statin types.
This study identified common ADRs across all statin types, including elevated Blood Creatine Phosphokinase, Chromaturia, and elevated Hepatic Enzymes. Furthermore, a shared ADR of elevated Blood Urea was observed across all statins except Pitavastatin. Specific ADRs, potentially attributable to their distinct pharmacokinetic properties and chemical structures, including hearing loss associated with Atorvastatin, skeletal-related ADRs with Rosuvastatin, and premature labor with Pravastatin. This pharmacovigilance study utilizing spontaneous reporting data revealed previously underrecognized statins safety signals. Findings suggest distinct reporting patterns among statins, warranting dedicated investigations into their clinical considerations.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) conducted an observational in Adverse drug reactions. Statins was evaluated on Adverse drug reactions (ADRs). A disproportionality analysis of the FAERS database identified distinct adverse drug reactions among statins, such as hearing loss with atorvastatin and skeletal-related ADRs with rosuvastatin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: